Evidence map›Paper›PMID 38501871›Full record

ArticlemBio2024

The acyl-CoA synthetase

Sarah Charital, Serena Shunmugam, Sheena Dass, Anna Maria Alazzi, Christophe-Sébastien Arnold, Nicholas J Katris, Samuel Duley, Nyamekye A Quansah, Fabien Pierrel, Jérôme Govin and 2 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Reference Gene Selection for RT-qPCR Normalization inInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sarah Charital *Apicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Serena Shunmugam *Apicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0001-6179-3292
Sheena DassApicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Anna Maria AlazziTeam Govin, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Christophe-Sébastien ArnoldApicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Nicholas J KatrisApicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Samuel DuleyApicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Nyamekye A QuansahApicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Fabien PierrelUniversité Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, Grenoble, France.ORCID 0000-0003-2083-3002
Jérôme GovinTeam Govin, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Yoshiki Yamaryo-BottéApicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0002-9349-4411
Cyrille Y BottéApicolipid Team, Institute for Advanced Biosciences, CNRS UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0002-2245-536X
Centre National de la Recherche Scientifique · FRInstitut polytechnique de Grenoble · FR

Funding

Agence Nationale de la Recherche (ANR) ANR-23-CE15-0009-01Agence Nationale de la Recherche (ANR) ApicoLipiAdapt grant ANR-21-CE44-0010Agence Nationale de la Recherche (ANR) Laboratoire d'Excellence Parafrap France grant ANR-11-LABX-0024CEFIPRA Project 6003-1Centre National de la Recherche Scientifique (CNRS) LIA-IRP CNRS Program Apicolipid projectFondation pour la Recherche Médicale (FRM) FRM EQU202103012700Region Auvergne Rhone-Alpes Grant IRICE Project GEMELIUniversite Grenoble Alpes IDEX ISP Apicolipid
6 · The paper itself

Abstract

Apicomplexa parasites cause major diseases such as toxoplasmosis and malaria that have major health and economic burdens. These unicellular pathogens are obligate intracellular parasites that heavily depend on lipid metabolism for the survival within their hosts. Their lipid synthesis relies on an essential combination of fatty acids (FAs) obtained from both

Indexed as

MalariaToxoplasmaToxoplasmosisFatty AcidsHumansLipid MetabolismNutrientsProtozoan ProteinsSaccharomyces cerevisiaeFatty AcidsNutrientsProtozoan ProteinsacylCoA synthetasefatty acidfatty acid metabolismlipidlipidomicsmotilityToxoplasma gondii

Identifiers

PMID38501871
PMCPMC11005404
OpenAlexW4392953288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.